Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic review and meta-analysis.
Therapeutic Advances in Hematology（2023）
摘要
Venetoclax-based therapy is an effective and safe option for RRMM patients, especially those with t(11;14).
更多查看译文
关键词
multiple myeloma,t(11,14),therapy,venetoclax
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要